ArticleScientific reports2025
Discriminative biomarker selection using hybrid multi-population evolutionary computation.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The rapid advancement of Deoxyribonucleic acid (DNA) sequencing technology has gained more attention, especially in interpreting high-dimensional, low-sample-size microarray data for disease identification. However, conventional gene selection techniques struggle to identify optimal biomarker subsets from gene data within a feasible time. To address this, we propose a novel hybrid method for robust cancer classification and biomarker discovery. To reduce the dimensionality of gene data while preserving biologically meaningful patterns, in the first stage of our approach, Kernel Principal Component Analysis (KPCA) is utilized. The refined gene subsets are then processed by the Multi-Population Gravitational Search Algorithm (GSA) known as MPKGSA with Opposition-Based Learning (OBL). The hybridization mechanism involves using OBL to generate a set of opposite solutions for each population, which is then integrated into the GSA update process. This process provides a more diverse exploration of the search space, preventing premature convergence on suboptimal gene subsets. The effectiveness of MPKGSA was evaluated on six microarray cancer datasets and a breast cancer single-nucleotide polymorphism (SNP) dataset from the National Center for Biotechnology Information (NCBI) Gene Expression Omnibus (GEO). Numerical results demonstrate that MPKGSA excels at balancing convergence and diversity, achieving high prediction accuracy with minimal biomarker subsets. Furthermore, it outperformed existing meta-heuristic methods, selecting a small number of gene biomarkers strongly correlated with the biological response class, confirming its utility for precise cancer identification and classification.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.